{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T19:20:30Z","timestamp":1773516030304,"version":"3.50.1"},"reference-count":78,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"am","delay-in-days":388,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.neurol.2024.03.001","type":"journal-article","created":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T13:19:08Z","timestamp":1710854348000},"page":"290-297","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Drug-resistant generalized epilepsies: Revisiting the frontiers of idiopathic generalized epilepsies"],"prefix":"10.1016","volume":"180","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8250-1455","authenticated-orcid":false,"given":"L.","family":"Gauer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Baer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.-P.","family":"Valenti-Hirsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"De Saint-Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Hirsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.neurol.2024.03.001_bib0395","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/epi.13709","article-title":"ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology","volume":"58","author":"Scheffer","year":"2017","journal-title":"Epilepsia"},{"issue":"6","key":"10.1016\/j.neurol.2024.03.001_bib0400","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1111\/epi.17236","article-title":"ILAE definition of the idiopathic generalized epilepsy syndromes: position statement by the ILAE Task Force on Nosology and Definitions","volume":"63","author":"Hirsch","year":"2022","journal-title":"Epilepsia"},{"issue":"10","key":"10.1016\/j.neurol.2024.03.001_bib0405","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/j.eplepsyres.2014.09.008","article-title":"Seizure outcome in 175 patients with juvenile myoclonic epilepsy\u00a0\u2013\u00a0A long-term observational study","volume":"108","author":"H\u00f6fler","year":"2014","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.neurol.2024.03.001_bib0410","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.seizure.2017.05.011","article-title":"Juvenile myoclonic epilepsy as a spectrum disorder: a focused review","volume":"49","author":"Baykan","year":"2017","journal-title":"Seizure"},{"issue":"4","key":"10.1016\/j.neurol.2024.03.001_bib0415","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/00005053-193604000-00002","article-title":"A study of the action of bromides in clinical and experimental epilepsy","volume":"83","author":"Boshes","year":"1936","journal-title":"J Nerv Ment Dis"},{"issue":"11","key":"10.1016\/j.neurol.2024.03.001_bib0420","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1001\/jama.1968.03140110005002","article-title":"Treatment of uncontrolled seizure activity with diazepam","volume":"203","author":"Sawyer","year":"1968","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.neurol.2024.03.001_bib0425","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1528-1167.2009.02397.x","article-title":"Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies: definition of drug resistant epilepsy","volume":"51","author":"Kwan","year":"2009","journal-title":"Epilepsia"},{"issue":"10","key":"10.1016\/j.neurol.2024.03.001_bib0430","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1093\/brain\/awr215","article-title":"The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol","volume":"134","author":"Shorvon","year":"2011","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.neurol.2024.03.001_bib0435","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/epi.14016","article-title":"Proposed consensus definitions for new-onset refractory status epilepticus (NORSE), febrile infection-related epilepsy syndrome (FIRES), and related conditions","volume":"59","author":"Hirsch","year":"2018","journal-title":"Epilepsia"},{"issue":"s9","key":"10.1016\/j.neurol.2024.03.001_bib0440","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1528-1167.2005.00316.x","article-title":"Status epilepticus in idiopathic generalized epilepsy","volume":"46","author":"Shorvon","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.neurol.2024.03.001_bib0445","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.2147\/NDT.S209084","article-title":"Status epilepticus in patients with genetic (idiopathic) generalized epilepsy","volume":"15","author":"Bosak","year":"2019","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"4","key":"10.1016\/j.neurol.2024.03.001_bib0450","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0896-6974(95)00033-X","article-title":"Development of intracranial tumors in patients with long-standing preexisting epilepsy","volume":"8","author":"Bartolomei","year":"1995","journal-title":"J Epilepsy"},{"issue":"5","key":"10.1016\/j.neurol.2024.03.001_bib0455","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1053\/seiz.1999.0303","article-title":"Tiagabine-induced absence status in idiopathic generalized epilepsy","volume":"8","author":"Knake","year":"1999","journal-title":"Seizure"},{"issue":"7","key":"10.1016\/j.neurol.2024.03.001_bib0460","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/j.1528-1157.2000.tb00258.x","article-title":"Refractory idiopathic absence status epilepticus: a probable paradoxical effect of phenytoin and carbamazepine","volume":"41","author":"Osorio","year":"2000","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.neurol.2024.03.001_bib0465","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1093\/brain\/awl047","article-title":"Absence and myoclonic status epilepticus precipitated by antiepileptic drugs in idiopathic generalized epilepsy","volume":"129","author":"Thomas","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2024.03.001_bib0470","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.yebeh.2015.04.034","article-title":"Drug-induced status epilepticus","volume":"49","author":"Cock","year":"2015","journal-title":"Epilepsy Behav"},{"issue":"1","key":"10.1016\/j.neurol.2024.03.001_bib0475","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/ng0501-46","article-title":"First genetic evidence of GABAA receptor dysfunction in epilepsy: a mutation in the \u03b32-subunit gene","volume":"28","author":"Baulac","year":"2001","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.neurol.2024.03.001_bib0480","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/ng0501-49","article-title":"Mutant GABAA receptor \u03b32-subunit in childhood absence epilepsy and febrile seizures","volume":"28","author":"Wallace","year":"2001","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.neurol.2024.03.001_bib0485","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/ng885","article-title":"Mutation of GABRA1 in an autosomal dominant form of juvenile myoclonic epilepsy","volume":"31","author":"Cossette","year":"2002","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.neurol.2024.03.001_bib0490","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.pediatrneurol.2007.06.001","article-title":"Genetic polymorphisms and idiopathic generalized epilepsies","volume":"37","author":"Lucarini","year":"2007","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.neurol.2024.03.001_bib0495","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.seizure.2021.10.013","article-title":"GABRA1 and GABRA6 gene mutations in idiopathic generalized epilepsy patients","volume":"93","author":"Riaz","year":"2021","journal-title":"Seizure"},{"issue":"4","key":"10.1016\/j.neurol.2024.03.001_bib0500","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1086\/319516","article-title":"Neuronal sodium-channel \u03b11-subunit mutations in generalized epilepsy with febrile seizures plus","volume":"68","author":"Wallace","year":"2001","journal-title":"Am J Hum Genet"},{"issue":"9","key":"10.1016\/j.neurol.2024.03.001_bib0505","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1212\/WNL.56.9.1245","article-title":"Association between the \u03b11a calcium channel gene CACNA1A and idiopathic generalized epilepsy","volume":"56","author":"Chioza","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2024.03.001_bib0510","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.pediatrneurol.2018.11.017","article-title":"Expanding the phenotypic spectrum of CACNA1H mutations","volume":"93","author":"Chourasia","year":"2019","journal-title":"Pediatr Neurol"},{"issue":"4","key":"10.1016\/j.neurol.2024.03.001_bib0515","article-title":"Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data. Cochrane Epilepsy Group, ed. Cochrane","volume":"2022","author":"Nevitt","year":"2022","journal-title":"Database Syst Rev"},{"issue":"9566","key":"10.1016\/j.neurol.2024.03.001_bib0520","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/S0140-6736(07)60461-9","article-title":"The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial","volume":"369","author":"Marson","year":"2007","journal-title":"Lancet"},{"issue":"10282","key":"10.1016\/j.neurol.2024.03.001_bib0525","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0140-6736(21)00246-4","article-title":"The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial","volume":"397","author":"Marson","year":"2021","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.neurol.2024.03.001_bib0530","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1111\/epi.13021","article-title":"Valproate in the treatment of epilepsy in girls and women of childbearing potential","volume":"56","author":"Tomson","year":"2015","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.neurol.2024.03.001_bib0535","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/bdr2.1967","article-title":"Transgenerational adverse effects of valproate? A patient report from 90 affected families","volume":"114","author":"Martin","year":"2022","journal-title":"Birth Defects Res"},{"key":"10.1016\/j.neurol.2024.03.001_bib0540","series-title":"EMA review of data on paternal exposure to valproate","year":"2023"},{"issue":"7","key":"10.1016\/j.neurol.2024.03.001_bib0545","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1111\/j.1528-1157.1999.tb00805.x","article-title":"Lamictal (Lamotrigine) monotherapy for typical absence seizures in children","volume":"40","author":"Frank","year":"1999","journal-title":"Epilepsia"},{"issue":"11","key":"10.1016\/j.neurol.2024.03.001_bib0550","article-title":"Topiramate for juvenile myoclonic epilepsy. Cochrane Epilepsy Group, ed","volume":"2021","author":"Liu","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.neurol.2024.03.001_bib0555","article-title":"Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents. Cochrane Epilepsy Group, ed","volume":"2021","author":"Brigo","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.neurol.2024.03.001_bib0560","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1684\/j.1950-6945.2004.tb00075.x","article-title":"Efficacy and tolerability of zonisamide in juvenile myoclonic epilepsy","volume":"6","author":"Kothare","year":"2004","journal-title":"Epileptic Disord Int Epilepsy J Videotape"},{"key":"10.1016\/j.neurol.2024.03.001_bib0565","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.eplepsyres.2005.11.007","article-title":"Zonisamide in the management of epilepsy\u2014Japanese experience","volume":"68","author":"Ohtahara","year":"2006","journal-title":"Epilepsy Res"},{"issue":"1","key":"10.1016\/j.neurol.2024.03.001_bib0570","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.eplepsyres.2009.02.016","article-title":"Levetiracetam as add-on therapy for idiopathic generalized epilepsy syndromes with onset during adolescence: analysis of two randomized, double-blind, placebo-controlled studies","volume":"85","author":"Rosenfeld","year":"2009","journal-title":"Epilepsy Res"},{"issue":"11","key":"10.1016\/j.neurol.2024.03.001_bib0575","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1212\/WNL.0000000000001930","article-title":"Perampanel for tonic-clonic seizures in idiopathic generalized epilepsy: a randomized trial","volume":"85","author":"French","year":"2015","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.neurol.2024.03.001_bib0580","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1136\/jnnp-2020-323524","article-title":"Efficacy and safety of adjunctive lacosamide in the treatment of primary generalised tonic-clonic seizures: a double-blind, randomised, placebo-controlled trial","volume":"91","author":"Vossler","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"10.1016\/j.neurol.2024.03.001_bib0585","doi-asserted-by":"crossref","first-page":"e669","DOI":"10.1212\/CPJ.0000000000000992","article-title":"Efficacy and tolerability of clobazam in adults with drug-refractory epilepsy","volume":"11","author":"Jamil","year":"2021","journal-title":"Neurol Clin Pract"},{"issue":"10","key":"10.1016\/j.neurol.2024.03.001_bib0590","doi-asserted-by":"crossref","first-page":"4713","DOI":"10.1007\/s00415-023-11834-8","article-title":"Antiseizure medications for idiopathic generalized epilepsies: a systematic review and network meta-analysis","volume":"270","author":"Chu","year":"2023","journal-title":"J Neurol"},{"issue":"6","key":"10.1016\/j.neurol.2024.03.001_bib0595","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.3171\/2011.7.JNS11977","article-title":"Vagus nerve stimulation for epilepsy: a meta-analysis of efficacy and predictors of response: a review","volume":"115","author":"Englot","year":"2011","journal-title":"J Neurosurg"},{"issue":"3","key":"10.1016\/j.neurol.2024.03.001_bib0600","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1111\/j.1528-1167.2011.03394.x","article-title":"Efficacy of the ketogenic diet: which epilepsies respond?","volume":"53","author":"Thammongkol","year":"2012","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.neurol.2024.03.001_bib0605","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1535-7511.2005.00061.x","article-title":"Seizure exacerbation by antiepileptic drugs","volume":"5","author":"French","year":"2005","journal-title":"Epilepsy Curr"},{"issue":"8","key":"10.1016\/j.neurol.2024.03.001_bib0610","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1111\/j.1528-1167.2012.03526.x","article-title":"Predictors for long-term seizure outcome in juvenile myoclonic epilepsy: 25\u201363 years of follow-up","volume":"53","author":"Geithner","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.neurol.2024.03.001_bib0615","series-title":"Epileptic seizures and syndromes","first-page":"143","article-title":"Perioral myoclonia with absences: a new syndrome","author":"Panayiotopoulos","year":"1994"},{"key":"10.1016\/j.neurol.2024.03.001_bib0620","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1528-1167.2009.02116.x","article-title":"Idiopathic generalized epilepsy (IGE) syndromes in development: IGE with absences of early childhood, IGE with phantom absences, and perioral myoclonia with absences","volume":"50","author":"Rubboli","year":"2009","journal-title":"Epilepsia"},{"issue":"s9","key":"10.1016\/j.neurol.2024.03.001_bib0625","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1528-1167.2005.00314.x","article-title":"Syndromes of idiopathic generalized epilepsies not recognized by the International League Against Epilepsy","volume":"46","author":"Panayiotopoulos","year":"2005","journal-title":"Epilepsia"},{"issue":"6","key":"10.1016\/j.neurol.2024.03.001_bib0630","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1111\/epi.17241","article-title":"International League Against Epilepsy classification and definition of epilepsy syndromes with onset in childhood: position paper by the ILAE Task Force on Nosology and Definitions","volume":"63","author":"Specchio","year":"2022","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.neurol.2024.03.001_bib0635","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1684\/epd.2021.1265","article-title":"Unmasking the entity of \u2018drug-resistant\u2019 perioral myoclonia with absences: the twitches, darts and domes!","volume":"23","author":"Rudrabhatla","year":"2021","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.neurol.2024.03.001_bib0640","series-title":"Idiopathic generalized epilepsies: clinical, experimental and genetic aspects","first-page":"87","article-title":"What are the relevant criteria for a better classification of epileptic syndromes with typical absences?","author":"Hirsch","year":"1994"},{"issue":"5","key":"10.1016\/j.neurol.2024.03.001_bib0645","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1136\/jnnp.63.5.622","article-title":"Idiopathic generalised epilepsy in adults manifested by phantom absences, generalised tonic-clonic seizures, and frequent absence status","volume":"63","author":"Panayiotopoulos","year":"1997","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"10.1016\/j.neurol.2024.03.001_bib0650","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1528-1157.2000.tb00229.x","article-title":"Distinct behavioral and EEG topographic correlates of loss of consciousness in absences","volume":"41","author":"Vuilleumier","year":"2000","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.neurol.2024.03.001_bib0655","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1684\/j.1950-6945.2001.tb00459.x","article-title":"Epigastric sensations as an unusual manifestation of adult absence epilepsy","volume":"3","author":"Wiest","year":"2001","journal-title":"Epileptic Disord Int Epilepsy J Videotape"},{"issue":"6","key":"10.1016\/j.neurol.2024.03.001_bib0660","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1528-1157.1984.tb03479.x","article-title":"Frontoparietal astrocytoma causing absence seizures and bilaterally synchronous epileptiform discharges","volume":"25","author":"Farwell","year":"1984","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.neurol.2024.03.001_bib0665","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1177\/155005949702800309","article-title":"Frontal lobe epilepsy with secondarily generalized 3\u00a0Hz spike-waves: a case report","volume":"28","author":"Kubota","year":"1997","journal-title":"Clin Electroencephalogr"},{"issue":"5","key":"10.1016\/j.neurol.2024.03.001_bib0670","doi-asserted-by":"crossref","first-page":"379","DOI":"10.2165\/00128072-200103050-00006","article-title":"Treatment of typical absence seizures and related epileptic syndromes","volume":"3","author":"Panayiotopoulos","year":"2001","journal-title":"Paediatr Drugs"},{"issue":"7","key":"10.1016\/j.neurol.2024.03.001_bib0675","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/nn.2132","article-title":"Seizure termination by acidosis depends on ASIC1a","volume":"11","author":"Ziemann","year":"2008","journal-title":"Nat Neurosci"},{"issue":"5","key":"10.1016\/j.neurol.2024.03.001_bib0680","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/j.1365-2125.2009.03521.x","article-title":"Effect of topiramate on acid\u2013base balance: extent, mechanism and effects","volume":"68","author":"Mirza","year":"2009","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.neurol.2024.03.001_bib0685","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1469-8749.1977.tb08014.x","article-title":"Nosological problems of myoclonic epilepsies in childhood and adolescence","volume":"19","author":"Jeavons","year":"1977","journal-title":"Dev Med Child Neurol"},{"issue":"1","key":"10.1016\/j.neurol.2024.03.001_bib0690","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/epi.17450","article-title":"Spectrum of epilepsy with eyelid myoclonia: delineation of disease subtypes from a large multicenter study","volume":"64","author":"Cerulli Irelli","year":"2023","journal-title":"Epilepsia"},{"issue":"11","key":"10.1016\/j.neurol.2024.03.001_bib0695","doi-asserted-by":"crossref","first-page":"5609","DOI":"10.3390\/ijms22115609","article-title":"Candidate genes for eyelid myoclonia with absences, review of the literature","volume":"22","author":"Mayo","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.neurol.2024.03.001_bib0700","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/epd2.20086","article-title":"Epilepsy with eyelid myoclonia in the setting of de novo pathogenic variant in ATP1A3","volume":"25","author":"Parfyonov","year":"2023","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.neurol.2024.03.001_bib0705","doi-asserted-by":"crossref","DOI":"10.1177\/2329048X231183524","article-title":"Refractory Jeavons syndrome from birth symptomatic to PLCB1 mutation","volume":"10","author":"Spurgeon","year":"2023","journal-title":"Child Neurol Open"},{"key":"10.1016\/j.neurol.2024.03.001_bib0710","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.seizure.2021.09.021","article-title":"Epilepsy in \u201cSunflower syndrome\u201d: electroclinical features, therapeutic response, and long-term follow-up","volume":"93","author":"Belcastro","year":"2021","journal-title":"Seizure"},{"issue":"4","key":"10.1016\/j.neurol.2024.03.001_bib0715","first-page":"311","article-title":"Familial adult myoclonic epilepsy (FAME): clinical features, molecular characteristics, pathophysiological aspects and diagnostic work-up","volume":"33","author":"Peters","year":"2022","journal-title":"Med Genet"},{"issue":"10","key":"10.1016\/j.neurol.2024.03.001_bib0720","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1212\/WNL.40.10.1561","article-title":"Cortical tremor: a variant of cortical reflex myoclonus","volume":"40","author":"Ikeda","year":"1990","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.neurol.2024.03.001_bib0725","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.3390\/cells12121617","article-title":"Familial adult myoclonus epilepsy: a non-coding repeat expansion disorder of cerebellar\u2013thalamic\u2013cortical loop","volume":"12","author":"Cuccurullo","year":"2023","journal-title":"Cells"},{"issue":"12","key":"10.1016\/j.neurol.2024.03.001_bib0730","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1002\/mds.20530","article-title":"Levetiracetam in patients with cortical myoclonus: a clinical and electrophysiological study","volume":"20","author":"Striano","year":"2005","journal-title":"Mov Disord"},{"issue":"10","key":"10.1016\/j.neurol.2024.03.001_bib0735","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1016\/j.clinph.2019.07.006","article-title":"Low-dose perampanel improves refractory cortical myoclonus by the dispersed and suppressed paroxysmal depolarization shifts in the sensorimotor cortex","volume":"130","author":"Oi","year":"2019","journal-title":"Clin Neurophysiol"},{"issue":"3","key":"10.1016\/j.neurol.2024.03.001_bib0740","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/brain\/120.3.479","article-title":"Generalized epilepsy with febrile seizures plus. A genetic disorder with heterogeneous clinical phenotypes","volume":"120","author":"Scheffer","year":"1997","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.neurol.2024.03.001_bib0745","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/1531-8249(199901)45:1<75::AID-ART13>3.0.CO;2-W","article-title":"Generalized epilepsy with febrile seizures plus: a common childhood-onset genetic epilepsy syndrome","volume":"45","author":"Singh","year":"1999","journal-title":"Ann Neurol"},{"issue":"12","key":"10.1016\/j.neurol.2024.03.001_bib0750","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1212\/WNL.0000000000004384","article-title":"Genetic epilepsy with febrile seizures plus: refining the spectrum","volume":"89","author":"Zhang","year":"2017","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.neurol.2024.03.001_bib0755","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1111\/epi.13057","article-title":"Summary of recommendations for the management of infantile seizures: Task Force Report for the ILAE Commission of Pediatrics","volume":"56","author":"Wilmshurst","year":"2015","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.neurol.2024.03.001_bib0760","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1111\/epi.17509","article-title":"Gain of function SCN1A disease-causing variants: expanding the phenotypic spectrum and functional studies guiding the choice of effective antiseizure medication","volume":"64","author":"Matricardi","year":"2023","journal-title":"Epilepsia"},{"issue":"11","key":"10.1016\/j.neurol.2024.03.001_bib0765","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1111\/epi.17743","article-title":"Prophecy or empiricism? Clinical value of predicting versus determining genetic variant functions","volume":"64","author":"Brunklaus","year":"2023","journal-title":"Epilepsia"},{"issue":"7","key":"10.1016\/j.neurol.2024.03.001_bib0770","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1111\/j.1528-1167.2009.02045.x","article-title":"Generalized-onset seizures with secondary focal evolution","volume":"50","author":"Williamson","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.neurol.2024.03.001_bib0775","doi-asserted-by":"crossref","first-page":"100555","DOI":"10.1016\/j.ebr.2022.100555","article-title":"Genetic generalized epilepsy and generalized onset seizures with focal evolution (GOFE)","volume":"19","author":"Lamy","year":"2022","journal-title":"Epilepsy Behav Rep"},{"key":"10.1016\/j.neurol.2024.03.001_bib0780","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.seizure.2023.11.016","article-title":"Generalized onset seizures with focal evolution (GOFE) \u2013 a largely unknown ictal variation in genetic generalized epilepsies","volume":"114","author":"Brandhoff","year":"2023","journal-title":"Seizure Eur J Epilepsy"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378724004715?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378724004715?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T12:46:18Z","timestamp":1713962778000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378724004715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":78,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S0035378724004715"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2024.03.001","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug-resistant generalized epilepsies: Revisiting the frontiers of idiopathic generalized epilepsies","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2024.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}